Higher susceptibility of cerebral cortex and striatum to sulfite neurotoxicity in sulfite oxidase-deficient rats

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 11, 2016, Pages 2063-2074

  Grings, Mateus ^a   Moura, Alana Pimentel ^a   Parmeggiani, Belisa ^a   Motta, Marcela Moreira ^a   Boldrini, Rafael Mello ^a   August, Pauline Maciel ^a   Matté, Cristiane ^a   Wyse, Angela T S ^a   Wajner, Moacir ^a,b   Leipnitz, Guilhian ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antioxidant defenses; Brain; Energy metabolism; Sulfite; Sulfite oxidase deficiency

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; DRINKING WATER; GLUTAMATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SULFITE; SULFITE OXIDASE; TUNGSTEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN CORTEX; CEREBELLUM; CITRIC ACID CYCLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; HOMEOSTASIS; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SUPPLEMENTATION;

EID: 84983543609     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.08.007     Document Type: Article

References (101)

1. [1] Johnson, J.L., Duran, M., Molybdenum Cofactor Deficiency and Isolated Sulfite Oxidase Deficiency. Scriver, C.R., Beaudet, A.L., Valle, D., Sly, W.S., (eds.) The Metabolic and Molecular Bases of Inherited Disease, 2001, McGraw-Hill, New York, 3181–3217.
2. [2] Feng, C., Tollin, G., Enemark, J.H., Sulfite oxidizing enzymes. Biochim. Biophys. Acta 1774 (2007), 527–539.
3. [3] Johnson-Winters, K., Tollin, G., Enemark, J.H., Elucidating the catalytic mechanism of sulfite oxidizing enzymes using structural, spectroscopic, and kinetic analyses. Biochemistry 49 (2010), 7242–7254.
4. [4] Chapman, K., Sulfite-containing pharmaceuticals. Can. Med. Assoc. J., 148, 1993, 714.
5. [5] Taylor, S.L., Higley, N.A., Bush, R.K., Sulfites in foods: uses, analytical methods, residues, fate, exposure assessment, metabolism, toxicity, and hypersensitivity. Adv. Food Res. 30 (1986), 1–76.
6. [6] Klein, J.M., Schwarz, G., Cofactor-dependent maturation of mammalian sulfite oxidase links two mitochondrial import pathways. J. Cell Sci. 125 (2012), 4876–4885.
7. [7] Mendel, R.R., Bittner, F., Cell biology of molybdenum. Biochim. Biophys. Acta 1763 (2006), 621–635.
8. [8] Wilson, H.L., Rajagopalan, K.V., The role of tyrosine 343 in substrate binding and catalysis by human sulfite oxidase. J. Biol. Chem. 279 (2004), 15105–15113.
9. [9] Schwarz, G., Molybdenum cofactor biosynthesis and deficiency. Cell. Mol. Life Sci. 62 (2005), 2792–2810.
10. [10] Reiss, J., Hahnewald, R., Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2. Hum. Mutat. 32 (2011), 10–18.
11. [11] Rupar, C.A., Gillett, J., Gordon, B.A., Ramsay, D.A., Johnson, J.L., Garrett, R.M., Rajagopalan, K.V., Jung, J.H., Bacheyie, G.S., Sellers, A.R., Isolated sulfite oxidase deficiency. Neuropediatrics 27 (1996), 299–304.
12. [12] Garrett, R.M., Johnson, J.L., Graf, T.N., Feigenbaum, A., Rajagopalan, K.V., Human sulfite oxidase R160Q: identification of the mutation in a sulfite oxidase-deficient patient and expression and characterization of the mutant enzyme. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6394–6398.
13. [13] Tan, W.H., Eichler, F.S., Hoda, S., Lee, M.S., Baris, H., Hanley, C.A., Grant, P.E., Krishnamoorthy, K.S., Shih, V.E., Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 116 (2005), 757–766.
14. [14] Reiss, J., Johnson, J.L., Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Hum. Mutat. 21 (2003), 569–576.
15. [15] Sass, J.O., Gunduz, A., Araujo Rodrigues Funayama, C., Korkmaz, B., Dantas Pinto, K.G., Tuysuz, B., Yanasse Dos Santos, L., Taskiran, E., de Fátima Turcato, M., Lam, C.W., Reiss, J., Walter, M., Yalcinkaya, C., Camelo Junior, J.S., Functional deficiencies of sulfite oxidase: Differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia. Brain and Development 32 (2010), 544–549.
16. [16] Bayram, E., Topcu, Y., Karakaya, P., Yis, U., Cakmakci, H., Ichida, K., Kurul, S.H., Molybdenum cofactor deficiency: review of 12 cases (MoCD and review). Eur. J. Paediatr. Neurol. 17 (2013), 1–6.
17. [17] Basheer, S.N., Waters, P.J., Lam, C.W., Acquaviva-Bourdain, C., Hendson, G., Poskitt, K., Hukin, J., Isolated sulfite oxidase deficiency in the newborn: lactic acidaemia and leukoencephalopathy. Neuropediatrics 38 (2007), 38–41.
18. [18] Chan, K.Y., Li, C.K., Lai, C.K., Ng, S.F., Chan, A.Y., Infantile isolated sulphite oxidase deficiency in a Chinese family: a rare neurodegenerative disorder. Hong Kong Med. J. 8 (2002), 279–282.
19. [19] Edwards, M., Roeper, J., Allgood, C., Chin, R., Santamaria, J., Wong, F., Schwarz, G., Whitehall, J., Investigation of molybdenum cofactor deficiency due to MOCS2 deficiency in a newborn baby. Meta Gene 3 (2015), 43–49.
20. [20] Vijayakumar, K., Gunny, R., Grunewald, S., Carr, L., Chong, K.W., DeVile, C., Robinson, R., McSweeney, N., Prabhakar, P., Clinical neuroimaging features and outcome in molybdenum cofactor deficiency. Pediatr. Neurol. 45 (2011), 246–252.
21. [21] Chen, L.W., Tsai, Y.S., Huang, C.C., Prenatal multicystic encephalopathy in isolated sulfite oxidase deficiency with a novel mutaion. Pediatr. Neurol. 51 (2014), 181–182.
22. [22] Bindu, P.S., Christopher, R., Mahadevan, A., Bharath, R.D., Clinical and imaging observations in isolated sulfite oxidase deficiency. J. Child Neurol. 26 (2011), 1036–1040.
23. [23] Per, H., Gümüş, H., Ichida, K., Cağlayan, O., Kumandaş, S., Molybdenum cofactor deficiency: clinical features in a Turkish patient. Brain Dev. 29 (2007), 365–368.
24. [24] Holder, J.L. Jr., Agadi, S., Reese, W., Rehder, C., Quach, M.M., Infantile spasms and hyperekplexia associated with isolated sulfite oxidase deficiency. JAMA Neurol. 71 (2014), 782–784.
25. [25] Parmeggiani, B., Moura, A.P., Grings, M., Bumbel, A.P., de Moura Alvorcem, L., Tauana Pletsch, J., Fernandes, C.G., Wyse, A.T., Wajner, M., Leipnitz, G., In vitro evidence that sulfite impairs glutamatergic neurotransmission and inhibits glutathione metabolism-related enzymes in rat cerebral cortex. Int. J. Dev. Neurosci. 42 (2015), 68–75.
26. [26] Grings, M., Moura, A.P., Parmeggiani, B., Marcowich, G.F., Amaral, A.U., de Souza Wyse, A.T., Wajner, M., Leipnitz, G., Disturbance of brain energy and redox homeostasis provoked by sulfite and thiosulfate: Potential pathomechanisms involved in the neuropathology of sulfite oxidase deficiency. Gene 531 (2013), 191–198.
27. [27] Chiarani, F., Bavaresco, C.S., Dutra-Filho, C.S., Netto, C.A., Wyse, A.T., Sulfite increases lipoperoxidation and decreases the activity of catalase in brain of rats. Metab. Brain Dis. 23 (2008), 123–132.
28. [28] Ozturk, O.H., Oktar, S., Aydin, M., Kucukatay, V., Effect of sulfite on antioxidant enzymes and lipid peroxidation in normal and sulfite oxidase-deficient rat erythrocytes. J. Physiol. Biochem. 66 (2010), 205–212.
29. [29] Herken, E.N., Kocamaz, E., Erel, O., Celik, H., Kucukatay, V., Effect of sulfite treatment on total antioxidant capacity, total oxidant status, lipid hydroperoxide, and total free sulfydryl groups contents in normal and sulfite oxidase-deficient rat plasma. Cell Biol. Toxicol. 25 (2009), 355–362.
30. [30] Mottley, C., Mason, R.P., Sulfate anion free radical formation by the peroxidation of (Bi)sulfite and its reaction with hydroxyl radical scavengers. Arch. Biochem. Biophys. 267 (1988), 681–689.
31. [31] Neta, P., Huie, R.E., Free-radical chemistry of sulfite. Environ. Health Perspect. 64 (1985), 209–217.
32. [32] Hayon, E., Treinin, A., Wilf, J., Electronic spectra, photochemistry, and autoxidation mechanism of the sulfite-bisulfite-pyrosulfite systems. The SO2 -, SO3 -, SO4 -, and SO5 - radicals. J. Am. Chem. Soc. 94 (1972), 47–57.
33. [33] Sadat-Shafaï, T., Pucheault, J., Ferradini, C., A radiolysis study of the role of superoxide ion in the oxidation of sulfite by oxygen. Radiat. Phys. Chem. 17 (1981), 283–288.
34. [34] Zhang, X., Vincent, A.S., Halliwell, B., Wong, K.P., A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. J. Biol. Chem. 279 (2004), 43035–43045.
35. [35] Grings, M., Moura, A.P., Amaral, A.U., Parmeggiani, B., Gasparotto, J., Moreira, J.C., Gelain, D.P., Wyse, A.T., Wajner, M., Leipnitz, G., Sulfite disrupts brain mitochondrial energy homeostasis and induces mitochondrial permeability transition pore opening via thiol group modification. Biochim. Biophys. Acta 1842 (2014), 1413–1422.
36. [36] Johnson, J.L., Rajagopalan, K.V., Cohen, H.J., Molecular basis of the biological function of molybdenum. Effect of tungsten on xanthine oxidase and sulfite oxidase in the rat. J. Biol. Chem. 249 (1974), 859–866.
37. [37] Cohen, H.J., Fridovich, I., Hepatic sulfite oxidase. Purification and properties. J. Biol. Chem. 246 (1971), 359–366.
38. [38] Rosenthal, R.E., Hamud, F., Fiskum, G., Varghese, P.J., Sharpe, S., Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7 (1987), 752–758.
39. [39] Mirandola, S.R., Melo, D.R., Schuck, P.F., Ferreira, G.C., Wajner, M., Castilho, R.F., Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J. Inherit. Metab. Dis. 31 (2008), 44–54.
40. [40] Fischer, J.C., Ruitenbeek, W., Berden, J.A., Trijbels, J.M.F., Veerkamp, J.H., Stadhouders, A.M., Sengers, R.C.A., Janssen, A.J.M., Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 153 (1985), 23–36.
41. [41] Rustin, P., Chretien, D., Bourgeron, T., Gerard, B., Rotig, A., Saudubray, J.M., Munnich, A., Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228 (1994), 35–51.
42. [42] da Silva, C.G., Ribeiro, C.A.J., Leipnitz, G., Dutra, C.S., Wyse, A.T.S., Wannmacher, C.M.D., Sarkis, J.J.F., Jakobs, C., Wajner, M., Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim. Biophys. Acta 1586 (2002), 81–91.
43. [43] Browne, R.W., Armstrong, D., Reduced glutathione and glutathione disulfide. Methods Mol. Biol. 108 (1998), 347–352.
44. [44] Aebi, H., Catalase in vitro. Methods Enzymol. 105 (1984), 121–126.
45. [45] Marklund, S., Pyrogallol autoxidation. Greenwald, R.A., (eds.) Handbook of Methods for Oxygen Radical Research, 1985, CRC Press, Boca Raton, FL, USA, 243–247.
46. [46] Carlberg, I., Mannervik, B., Glutathione reductase. Methods Enzymol. 113 (1985), 484–490.
47. [47] Mannervik, B., Guthenberg, C., Glutathione transferase (human placenta). Methods Enzymol. 77 (1981), 231–235.
48. [48] Leong, S.F., Clark, J.B., Regional development of glutamate dehydrogenase in the rat brain. J. Neurochem. 43 (1984), 106–111.
49. [49] Shepherd, D., Garland, P.B., Citrate synthase from rat liver. Methods Enzymol. 13 (1969), 11–13.
50. [50] Plaut, G.W.E., Isocitrate dehydrogenase from bovine heart. Methods Enzymol. 13 (1969), 34–42.
51. [51] Kitto, G.B., Intra- and extramitochondrial malate dehydrogenase from chicken and tuna heart. Methods Enzymol. 13 (1969), 106–116.
52. [52] Colon, A.D., Plaitakis, A., Perakis, A., Berl, S., Clarke, D.D., Purification and characterization of a soluble and a particulate glutamate dehydrogenase from rat brain. J. Neurochem. 46 (1986), 1811–1819.
53. [53] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
54. [54] Schwahn, B.C., Van Spronsen, F.J., Belaidi, A.A., Bowhay, S., Christodoulou, J., Derks, T.G., Hennermann, J.B., Jameson, E., Konig, K., McGregor, T.L., Font-Montgomery, E., Santamaria-Araujo, J.A., Santra, S., Vaidya, M., Vierzig, A., Wassmer, E., Weis, I., Wong, F.Y., Veldman, A., Schwarz, G., Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. Lancet 386 (2015), 1955–1963.
55. [55] Higuchi, R., Sugimoto, T., Tamura, A., Kioka, N., Tsuno, Y., Higa, A., Yoshikawa, N., Early features in neuroimaging of two siblings with molybdenum cofactor deficiency. Pediatrics 133 (2014), e267–e271.
56. [56] Eichler, F., Tan, W.H., Shih, V.E., Grant, P.E., Krishnamoorthy, K., Proton magnetic resonance spectroscopy and diffusion-weighted imaging in isolated sulfite oxidase deficiency. J. Child Neurol. 21 (2006), 801–805.
57. [57] Yoshida, M., Nakagawa, M., Hosomi, R., Nishiyama, T., Fukunaga, K., Low molybdenum state induced by tungsten as a model of molybdenum deficiency in rats. Biol. Trace Elem. Res. 165 (2015), 75–80.
58. [58] Ranguelova, K., Rice, A.B., Khajo, A., Triquigneaux, M., Garantziotis, S., Magliozzo, R.S., Mason, R.P., Formation of reactive sulfite-derived free radicals by the activation of human neutrophils: an ESR study. Free Radic. Biol. Med. 52 (2012), 1264–1271.
59. [59] Gunnison, A.F., Sulphite toxicity: a critical review of in vitro and in vivo data. Food Cosmet. Toxicol. 19 (1981), 667–682.
60. [60] Yu, C., Luo, M., Zeng, F., Wu, S., A fast-responding fluorescent turn-on sensor for sensitive and selective detection of sulfite anions. Anal. Methods 4 (2012), 2638–2640.
61. [61] Gunnison, A.F., Palmes, E.D., Persistence of plasma S-sulfonates following exposure of rabbits to sulfite and sulfur dioxide. Toxicol. Appl. Pharmacol. 24 (1973), 266–278.
62. [62] Gunnison, A.F., Jacobsen, D.W., Sulfite hypersensitivity. A critical review. CRC Crit. Rev. Toxicol. 17 (1987), 185–214.
63. [63] Ozturk, N., Yargicoglu, P., Derin, N., Akpinar, D., Agar, A., Aslan, M., Dose-dependent effect of nutritional sulfite intake on visual evoked potentials and lipid peroxidation. Neurotoxicol. Teratol. 33 (2011), 244–254.
64. [64] Halliwell, B., Gutteridge, J., Measurement of reactive species. Halliwell, B., Gutteridge, J., (eds.) Free Radicals in Biology and Medicine, 2007, Oxford University Press Inc., New York, 268–340.
65. [65] Schafer, F.Q., Buettner, G.R., Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001), 1191–1212.
66. [66] Deponte, M., Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta 1830 (2013), 3217–3266.
67. [67] Lu, S.C., Glutathione synthesis. Biochim. Biophys. Acta 1830 (2013), 3143–3153.
68. [68] Leung, K.H., Post, G.B., Menzel, D.B., Glutathione S-sulfonate, a sulfur dioxide metabolite, as a competitive inhibitor of glutathione S-transferase, and its reduction by glutathione reductase. Toxicol. Appl. Pharmacol. 77 (1985), 388–394.
69. [69] Keller, D.A., Menzel, D.B., Effects of sulfite on glutathione S-sulfonate and the glutathione status of lung cells. Chem. Biol. Interact. 70 (1989), 145–156.
70. [70] Murakami, K., Tsubouchi, R., Fukayama, M., Yoshino, M., Copper-dependent inhibition and oxidative inactivation with affinity cleavage of yeast glutathione reductase. Biometals 27 (2014), 551–558.
71. [71] Ricci, G., Del Boccio, G., Pennelli, A., Lo Bello, M., Petruzzelli, R., Caccuri, A.M., Barra, D., Federici, G., Redox forms of human placenta glutathione transferase. J. Biol. Chem. 266 (1991), 21409–21415.
72. [72] Shen, H., Tsuchida, S., Tamai, K., Sato, K., Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide. Arch. Biochem. Biophys. 300 (1993), 137–141.
73. [73] Singh, P., Jain, A., Kaur, G., Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol. Cell. Biochem. 260 (2004), 153–159.
74. [74] Aoyama, K., Nakaki, T., Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1). Molecules 20 (2015), 8742–8758.
75. [75] Espinosa-Diez, C., Miguel, V., Mennerich, D., Kietzmann, T., Sanchez-Perez, P., Cadenas, S., Lamas, S., Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 6 (2015), 183–197.
76. [76] Ahmed, A., Malik, A., Jagirdar, H., Rabbani, N., Khan, M.S., Al-Senaidy, A.M., Ismael, M.A., Copper-Induced Inactivation of Camel Liver Glutathione S-Transferase. Biol. Trace Elem. Res. 169 (2016), 69–76.
77. [77] Kucukatay, V., Hacioglu, G., Savcioglu, F., Yargicoglu, P., Agar, A., Visual evoked potentials in normal and sulfite oxidase deficient rats exposed to ingested sulfite. Neurotoxicology 27 (2006), 93–100.
78. [78] Ozsoy, O., Aras, S., Ozkan, A., Parlak, H., Aslan, M., Yargicoglu, P., Agar, A., The effect of ingested sulfite on visual evoked potentials, lipid peroxidation, and antioxidant status of brain in normal and sulfite oxidase-deficient aged rats. Toxicol. Ind. Health, 2014.
79. [79] Arnold, S., The power of life–cytochrome c oxidase takes center stage in metabolic control, cell signalling and survival. Mitochondrion 12 (2012), 46–56.
80. [80] Vincent, A.S., Lim, B.G., Tan, J., Whiteman, M., Cheung, N.S., Halliwell, B., Wong, K.P., Sulfite-mediated oxidative stress in kidney cells. Kidney Int. 65 (2004), 393–402.
81. [81] Rhein, V., Baysang, G., Rao, S., Meier, F., Bonert, A., Muller-Spahn, F., Eckert, A., Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell. Mol. Neurobiol. 29 (2009), 1063–1071.
82. [82] Sauer, S.W., Opp, S., Haarmann, A., Okun, J.G., Kolker, S., Morath, M.A., Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias. J. Inherit. Metab. Dis. 32 (2009), 720–727.
83. [83] Brannan, T.S., Maker, H.S., Weiss, C., Cohen, G., Regional distribution of glutathione peroxidase in the adult rat brain. J. Neurochem. 35 (1980), 1013–1014.
84. [84] Halliwell, B., Gutteridge, J., Reactive species and disease: fact, fiction or filibuster?. Halliwell, B., Gutteridge, J., (eds.) Free Radicals in Biology and Medicine, 2007, Oxford University Press Inc., New York, 488–613.
85. [85] Friberg, H., Connern, C., Halestrap, A.P., Wieloch, T., Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J. Neurochem. 72 (1999), 2488–2497.
86. [86] Dubinsky, J.M., Heterogeneity of nervous system mitochondria: location, location, location!. Exp. Neurol. 218 (2009), 293–307.
87. [87] Brustovetsky, N., Brustovetsky, T., Purl, K.J., Capano, M., Crompton, M., Dubinsky, J.M., Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 23 (2003), 4858–4867.
88. [88] Albin, R.L., Greenamyre, J.T., Alternative excitotoxic hypotheses. Neurology 42 (1992), 733–738.
89. [89] Nishino, H., Hida, H., Kumazaki, M., Shimano, Y., Nakajima, K., Shimizu, H., Ooiwa, T., Baba, H., The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J. Neurotrauma 17 (2000), 251–260.
90. [90] Zaidan, E., Sims, N.R., Reduced activity of the pyruvate dehydrogenase complex but not cytochrome c oxidase is associated with neuronal loss in the striatum following short-term forebrain ischemia. Brain Res. 772 (1997), 23–28.
91. [91] Dagani, F., Marzatico, F., Curti, D., Taglietti, M., Zanada, F., Benzi, G., Influence of intermittent hypoxia and pyrimidinic nucleosides on cerebral enzymatic activities related to energy transduction. Neurochem. Res. 9 (1984), 1085–1099.
92. [92] Mirandola, S.R., Melo, D.R., Saito, A., Castilho, R.F., 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions. J. Neurosci. Res. 88 (2010), 630–639.
93. [93] Woo, W.H., Yang, H., Wong, K.P., Halliwell, B., Sulphite oxidase gene expression in human brain and in other human and rat tissues. Biochem. Biophys. Res. Commun. 305 (2003), 619–623.
94. [94] Sauerbeck, A., Pandya, J., Singh, I., Bittman, K., Readnower, R., Bing, G., Sullivan, P., Analysis of regional brain mitochondrial bioenergetics and susceptibility to mitochondrial inhibition utilizing a microplate based system. J. Neurosci. Methods 198 (2011), 36–43.
95. [95] Austin, S.A., Santhanam, A.V., d'Uscio, L.V., Katusic, Z.S., Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress. PLoS One, 10, 2015, e0144062.
96. [96] Schmitz, F., Scherer, E.B., Machado, F.R., da Cunha, A.A., Tagliari, B., Netto, C.A., Wyse, A.T., Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab. Brain Dis. 27 (2012), 605–612.
97. [97] Bertoldi, K., Spindler, C., dos Santos Moyses, F., Vanzella, C., Lovatel, G.A., Elsner, V.R., Rodrigues, M.A., Siqueira, I.R., Effect of landfill leachate on oxidative stress of brain structures and liver from rodents: modulation by photoelectrooxidation process. Ecotoxicol. Environ. Saf. 84 (2012), 319–324.
98. [98] Hobson, E.E., Thomas, S., Crofton, P.M., Murray, A.D., Dean, J.C., Lloyd, D., Isolated sulphite oxidase deficiency mimics the features of hypoxic ischaemic encephalopathy. Eur. J. Pediatr. 164 (2005), 655–659.
99. [99] Eyaid, W.M., Al-Nouri, D.M., Rashed, M.S., Al-Rifai, M.T., Al-Wakeel, A.S., An inborn error of metabolism presenting as hypoxic-ischemic insult. Pediatr. Neurol. 32 (2005), 134–136.
100. [100] Hoffmann, C., Ben-Zeev, B., Anikster, Y., Nissenkorn, A., Brand, N., Kuint, J., Kushnir, T., Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency. J. Child Neurol. 22 (2007), 1214–1221.
101. [101] Stence, N.V., Coughlin, C.R. 2nd, Fenton, L.Z., Thomas, J.A., Distinctive pattern of restricted diffusion in a neonate with molybdenum cofactor deficiency. Pediatr. Radiol. 43 (2013), 882–885.